Fifth Third Bancorp Trims Stake in Merck & Co., Inc.

Fifth Third Bancorp reduced its stake in Merck & Co., Inc. shares by 2.8% during the second quarter, according to a recent filing with the SEC. The investor owned approximately 0.06% of Merck's stock, worth $192,830,000 at the end of the period.

The institutional investor sold 42,778 shares during this time, bringing its total ownership to 1,500,619 shares. Merck & Co., Inc. is a global biopharmaceutical company with a diverse portfolio spanning multiple therapeutic areas, including oncology and vaccines.